Skip to research content
Back to insiders

Jeppe Øvlesen

Follow this party across linked issuers and source filings.

PartySE · FISweden public disclosures

Companies in disclosed relationships

1

Public filings · 12 months

0

Net disclosed balance · 12 months

€0.00

Latest filing

25 Mar 2024

Signals are not available for this disclosure jurisdiction.

Recent filings

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

Recent public filings linked to this insider party
DateCompanyGross reported valueOpen
25 Mar 2024SynAct Pharma ABOther

SEK 1,696,503.00

Buy/sale net: SEK 0.00
Open
17 Jan 2023SynAct Pharma ABBuy

SEK 72,727,240.20

Buy/sale net: SEK 72,727,240.20
Open
17 Jan 2023SynAct Pharma ABBuy

SEK 865,445.00

Buy/sale net: SEK 865,445.00
Open

SynAct Pharma AB

25 Mar 2024
Other

Gross reported value

SEK 1,696,503.00

Evidence

SynAct Pharma AB

17 Jan 2023
Buy

Gross reported value

SEK 72,727,240.20

Evidence

SynAct Pharma AB

17 Jan 2023
Buy

Gross reported value

SEK 865,445.00

Evidence

Network and companies

1 distinct company in the disclosed relationships. Network coverage is a separate preview.